MobiHealth News July 22, 2024
Duke-NUS Medical School’s LIVE Ventures will bring together scientists and public and private sector entities to commercialize academic research concepts.
Duke-NUS Medical School is launching a $20 million incubator, LIVE Ventures, to help commercialize academic research projects and transform scientific breakthroughs into clinical applications.
The incubator aims to supply academic innovators with expertise and resources from the public and private sectors – including pharmaceutical companies, market data research professionals, investors, and industry experts – to conduct product-market fit evaluations for project commercialization.
An Investment Advisory Committee was established to determine the experience of the experts who will advise on commercializing the products. The initiative will kick off with a pilot project focused on chronic inflammatory diseases.
Through the...